Assessment of correlation among bone density, bone strength and biomarkers in glucocorticoid-induced osteoporosis

Assessment of correlation among bone density, bone strength and biomarkers in glucocorticoid-induced osteoporosis - Bone density, bone strength and biomarkers in GIO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007187

Enrollment

Registered

2012-02-01

Start date

2010-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucocorticoid-induced osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: treatment of more than PSL 5mg/day for 2 years

Exclusion criteria

Exclusion criteria: 1, started of medication for osteoporosis 2, diabetes 3, hypertyroidism 4, hyperparatyroidism 5, liver cirrhosis 6, renal dysfunction 7, inflammatory bowel disease 8, warfarization 9, pregnancy, lactation 10, fracture in the past

Design outcomes

Primary

Measure	Time frame
correlation and change of bone density, bone strength and biomarkers	—

Secondary

Measure	Time frame
relationship between fracture and bone density, bone strength and biomarkers	—

Countries

Japan

Contacts

Public ContactHiroko Kanda

University of Tokyo Department of Allergy and Rheumatorogy

hknada-kty@umin.ac.jp81-03-3815-5411

Outcome results